ScottC.KoganMD

Pathology • San Francisco, CA

Hematopathology, Anatomic Pathology, Clinical Pathology

Professor, Laboratory Medicine, UCSF School of Medicine

Join to view full profile

Dr. Kogan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kogan's full profile

Already have an account?

Office
505 Parnassus Ave
Fl 5
San Francisco, CA 94143
Phone+1 415-514-1590

Fax+1 415-353-1106

Education & Training

University of California (San Francisco)Fellowship, Hematopathology, 1997 - 1998
University of California (San Francisco) School of MedicineInternship, Transitional Year, 1992 - 1993
University of California (San Francisco)Residency, Pathology-Anatomic and Clinical, 1991 - 1993
University of California San Francisco School of MedicineClass of 1991

Certifications & Licensure

CA State Medical License 1993 - 2025
American Board of Pathology Clinical Pathology
American Board of Pathology Hematology

Publications & Presentations

PubMed

Early-life tobacco exposure is causally implicated in aberrant RAG-mediated recombination in childhood acute lymphoblastic leukemia.
Tanxin Liu, Keren Xu, Anmol Pardeshi, Swe Swe Myint, Alice Y Kang
Leukemia. 2024-11-01
1 citations
Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology Group.
Elliot Stieglitz, Alex G Lee, Steven P Angus, Christopher Davis, Donald A Barkauskas
Cancer Discovery. 2024-09-04
LNK/as a novel driver in juvenile myelomonocytic leukemia.
Astrid Wintering, Anna Hecht, Julia Meyer, Eric B Wong, Juwita Hübner
Haematologica. 2024-08-01

Press Mentions

Stromal Cells Downregulate miR-23a-5p to Activate Protective Autophagy in Acute Myeloid LeukemiaSeptember 30th, 2019

Grant Support

Molecular Mechanisms Of Leukemogenesis By Pmlrar AlphaNational Cancer Institute2002–2012
Pathogenesis And Therapy Of Acute Promyelocytic LeukemiaNational Cancer Institute1999–2003